Clinical Trial Update: Lactobacillus Reuteri Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Lactobacillus reuteri to alleviate oral mucositis in patients undergoing radiotherapy for head and neck cancer; study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Lactobacillus reuteri (Lactobacillus reuteri)

Snippet

Sponsor: West China Hospital | Conditions: Head and Neck Malignant Tumors | Phase 2 | Status: COMPLETED